Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Prostate Cancer

Immune System Agents May Move Into Earlier Settings

Over the past 5 years, medical oncologists have witnessed the revolutionary impact of immunotherapy on patients with advanced urologic malignancies. Over the next 5 years, these therapies likely will similarly transform urologic surgical care.
Read More >>

SM-88 Shows Efficacy in Pancreatic, Prostate Cancers

ASCO 2019: Enzalutamide Increases Survival in mHSPC Over Other Anti-Androgens

ASCO 2019: Apalutamide Extends Survival in Metastatic Castration-Sensitive Prostate Cancer

FDA Grants Fast Track Designation to ARV-110 for mCRPC

PARP Inhibition Appears Promising in CRPC, But Questions Remain

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

Dr. Fizazi Discusses Updated Data With Darolutamide in CRPC

Dr. Choudhury on the Importance of Volume Status in Metastatic Prostate Cancer

Dr. Dorff Discusses the Use of PARP Inhibitors in Prostate Cancer

Dr. McGregor on Data Evaluating the Link Between Cardiac Complications and ADT in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Favorable-Risk mRCC: Choosing Appropriate Frontline Therapy

Chemotherapy for BRCA-Mutated Prostate Cancer

PARP Inhibitors in Advanced Prostate Cancers

Therapeutic Sequencing for CRPC Based on Recent Data

Earlier Detection of Prostate Cancer Bone Metastases

Assessment of Bone Health in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Standard of Care in Metastatic Prostate Cancer

Adverse Effects of Hormone Therapy in Prostate Cancer

The Cardioprotective Role of Androgens

Further Therapeutic Strategies in Metastatic CRPC

Practical Applications of ERA 223 in the mCRPC Paradigm

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

OncLive News Network On Location: In Chicago